World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
6984
World Ranking
4797
National Ranking
5

Abbas Mirshafiey publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Abbas Mirshafiey sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 268 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Abbas Mirshafiey D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Abbas Mirshafiey sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Abbas Mirshafiey is affiliated with Tehran University of Medical Sciences in Iran. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focused interest in several subfields such as Pharmacology, Rheumatology, Immunology, Oncology, and Molecular Biology.

The scientist's work covers a range of topics including:

  • Cytokine Signaling Pathways and Interactions
  • Rheumatoid Arthritis Research and Therapies
  • Inflammatory mediators and NSAID effects
  • MicroRNA in disease regulation
  • Immunodeficiency and Autoimmune Disorders
  • Multiple Sclerosis Research Studies
  • Circular RNAs in diseases

Recent publications by Abbas Mirshafiey include:

  • "A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases," 2020, Immunology Letters
  • "Efficient roles of miR-146a in cellular and molecular mechanisms of neuroinflammatory disorders: An effectual review in neuroimmunology," 2021, Immunology Letters
  • "Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs," 2021, International Immunopharmacology
  • "Digging for the Discovery of SARS-CoV-2 nsp12 Inhibitors: A Pharmacophore-Based and Molecular Dynamics Simulation Study," 2022, Future Virology
  • "Lymphocytes subsets in correlation with clinical profile in CVID patients without monogenic defects," 2021, Expert Review of Clinical Immunology

Frequent co-authors in Abbas Mirshafiey's publications include:

  • Mona Aslani
  • Zahra Aghazadeh
  • Seyed Shahabeddin Mortazavi-Jahromi
  • Reza Yazdani
  • Arman Ahmadzadeh

The scientist's works are often published in venues such as:

  • The Journal of Clinical Pharmacology
  • Biomedical Journal of Scientific & Technical Research
  • Immunopharmacology and Immunotoxicology
  • Iranian Journal of Allergy Asthma and Immunology
  • Immunology Letters

Best Publications

  • Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis

    F. Jadidi-Niaragh;A. Mirshafiey

  • Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis

    Mohammad Hassan Javanbakht;Seyed Ali Keshavarz;Mahmoud Djalali;Fereydoun Siassi

  • The Role of Reactive Oxygen Species in Immunopathogenesis of Rheumatoid Arthritis

    Abbas Mirshafiey;Monireh Mohsenzadegan

  • Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis

    Gholamreza Azizi;Farhad Jadidi-Niaragh;Abbas Mirshafiey

  • Prostaglandins and rheumatoid arthritis.

    Mohammad Javad Fattahi;Abbas Mirshafiey

  • Antioxidant therapy in multiple sclerosis

    Abbas Mirshafiey;Monireh Mohsenzadegan

  • The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid Arthritis

    Maryam Gol-Ara;Farhad Jadidi-Niaragh;Reza Sadria;Gholamreza Azizi

  • Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.

    Farhad Jadidi-Niaragh;Abbas Mirshafiey

  • The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis

    Gholamreza Azizi;Nikoo Khannazer;Abbas Mirshafiey

  • The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.

    Gholamreza Azizi;Abbas Mirshafiey

  • The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.

    Abbas Mirshafiey;Babak Asghari;Ghasem Ghalamfarsa;Farhad Jadidi-Niaragh

  • T-Cell Abnormalities in Common Variable Immunodeficiency.

    G Azizi;G Azizi;N Rezaei;N Rezaei;F Kiaee;F Kiaee;N Tavakolinia;N Tavakolinia

  • TGF-β as a promising option in the treatment of multiple sclerosis

    Abbas Mirshafiey;Monireh Mohsenzadegan

  • The neglected role of histamine in Alzheimer's disease.

    Fatemeh Naddafi;Abbas Mirshafiey

  • The immunopathogenic role of reactive oxygen species in Alzheimer disease.

    Monireh Mohsenzadegan;Abbas Mirshafiey

  • The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

    Gholamreza Azizi;Shadi S. Navabi;Ahmed Al-Shukaili;Mir H. Seyedzadeh

  • Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.

    Sima Sh. Farid;Gholamreza Azizi;Abbas Mirshafiey

  • Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis.

    Abbas Mirshafiey;Hidenori Matsuo;Shunya Nakane;Bernd H A Rehm

  • Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial.

    Mohammad Khalili;Amirreza Azimi;Vajihe Izadi;Shahryar Eghtesadi

  • Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway.

    Ali Masjedi;Hadi Hassannia;Fatemeh Atyabi;Ali Rastegari

  • Th22 cells in autoimmunity: a review of current knowledge.

    Azizi G;Yazdani R;Mirshafiey A

Frequent Co-Authors

Gholamreza Azizi
Gholamreza Azizi Alborz University of Medical Sciences
Asghar Aghamohammadi
Asghar Aghamohammadi Tehran University of Medical Sciences
Nima Rezaei
Nima Rezaei Tehran University of Medical Sciences
Bernd H. A. Rehm
Bernd H. A. Rehm Griffith University
Farhad Jadidi-Niaragh
Farhad Jadidi-Niaragh Tabriz University of Medical Sciences
Salvatore Cuzzocrea
Salvatore Cuzzocrea University of Messina
Mahmood Jeddi-Tehrani
Mahmood Jeddi-Tehrani Avicenna Research Institute
John P. Kirwan
John P. Kirwan Pennington Biomedical Research Center
Mohammad Reza Zali
Mohammad Reza Zali Shahid Beheshti University of Medical Sciences
Craig I Coleman
Craig I Coleman University of Connecticut

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in immunology can open diverse pathways within the healthcare sector, especially when combined with nursing advanced practice programs. Many professionals consider attaining a doctor of nursing practice salary by advancing their education, which highlights the financial benefits of further specialization.

For those aiming to specialize in critical care, exploring acute care nurse practitioner programs is an effective way to expand clinical skills. Transitioning from family to acute care nursing qualifications allows professionals to engage with complex patient cases and broaden their impact.

Many students seek fast-tracked routes, such as the accelerated fnp programs, which provide a quicker path to becoming a family nurse practitioner. These online programs are designed for motivated learners balancing work and study.

Additionally, individuals without a nursing background can enter the field through 12-month accelerated nursing programs online for non nurses. These programs facilitate a smooth transition into nursing, enabling students to combine their interest in immunology with a clinical profession efficiently.

Best Scientists Citing Abbas Mirshafiey

Trending Scientists

Recently Published Articles